Program participants include physician-scientists and investigators from multiple institutes within the National Institutes of Health (NIH) including the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Human Genome Research Institute (NHGRI). If you are interested in participating in the trans-NIH Myeloid Malignancies Program, please contact a member of our leadership.
Kenneth Aldape, MD (NCI-CCR/LP)
Danielle Arnold, MD (NCI-CCR/ID-CTP)
Raul Braylan, MD (NIH/CC)
Alice Chen, MD (NCI/DCTD)
Laura Dillon, PhD (NIH/NHLBI)
James Doroshow, MD (NCI/DCTD)
Najla El Jurdi, MD (NCI-CCR/ID-CTP)
Grace-Ann Fasaye, ScM (NCI-CCR/GB)
Courtney Fitzhugh, MD (NIH/NHLBI)
Michael Gottesman, MD (NCI-CCR/LCB)
Dennis Hickstein, MD (NCI-CCR/ID-CTP)
Christopher Kanakry, MD (NCI-CCR/CIO)
Rosandra Kaplan, MD (NCI-CCR/POB)
Vid Leko, MD (NCI-CCR/ID-CTP)
Rich Little, MD (NCI/DCTD)
Paul Liu, PhD (NIH/NHGRI)
Yi Liu, MS, CGC (NCI-CCR/GB)
Lisa McReynolds, MD, PhD (NCI/DCEG)
Alain Mina, MD (NCI-CCR/ID-CTP)
Lindsay Morton, PhD (NCI/DCEG)
Shalini Oberdoerffer, PhD (NCI-CCR/LRBGE)
Bhavisha Patel, MD (NIH/NHLBI)
Eduard Schulz, MD (NIH/NCI)
John Shern, MD (NCI-CCR/POB)
Naoko Takebe, MD, PhD (NCI/DCTD)
Lori Wiener, PhD, DCSW, LCSW-C (NCI-CCR/POB)